Please assess the completion status of the following clinical trial:

Trial Title: Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* uncontrolled persistent asthmatics on daily inhaled corticosteroids (GINA)~Exclusion Criteria:~* viral/fungal/bacterial infection +fever (\<1 month)~* asthma exacerbation (\<3 months)~* other respiratory disease (CF, ciliary dyskinesia,bronchiectasis)~* cardiac patients using beta-blockers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Montelukast (Type: ACTIVE_COMPARATOR): None
- long-acting beta2-mimetic (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).